Kaya Holdings, Inc. looks to combat the Opioid Epidemic with Cannabis-for-Opioids Swap Program
Program is intended to offer cannabis products in exchange for opioids in cooperation with law enforcement authorities and compliance requirements
LEBANON, Ore., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Kaya Holdings, Inc. (OTCQB:KAYS), announced today that it will be holding talks with Oregon state and local law enforcement authorities and compliance officials to launch “Kaya Cares,” a Cannabis-for-Opioids swap program whereby people dependent on opioids and wishing to explore cannabis as a safe alternative can exchange their prescription opioids for cannabis products at no cost.
“We decided to step up and do our part after President Trump announced the war on the opioid epidemic,” commented Kaya Holdings CEO Craig Frank, “Numerous studies, including those reported by Newsweek, NBC News, US News and World Report, CNN and others, have shown that states with legal marijuana programs have declining rates of opioid addiction, with some states reporting a decrease in deaths as high as 25%. We want to help people in the communities we serve, as well as demonstrate that cannabis companies can be part of the President’s solution to the crisis.”
KAYS presently operates three Kaya Shack™ marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, with a fourth retail outlet scheduled to open shortly. Additionally, KAYS recently acquired a 26 acre parcel in Lebanon, Oregon, on which it plans to develop the Kaya Farms™ medical and recreational marijuana grow and manufacturing complex, at which it plans to explore development of opioid-free cannabis infused pain relief alternatives.
Adds KAYS Senior Advisor, W. David Jones, “The opioid epidemic kills an average of 91 Americans a day. Beyond the human cost in lives and devastated families, the epidemic disrupts our economy with reduced productivity and increased healthcare costs. We realize this administration has been reviewing its stance on legal marijuana and we appreciate US Attorney Jeff Sessions’ clarification to Congress regarding the Cole Amendment. We wish to heed President Trump’s call to create constructive, private sector based initiatives with high probabilities of success. We believe a program like Kaya Cares and other initiatives to be undertaken by KAYS will help transition people away from dangerous opioids, making the government’s war on opioids a little more successful.”
Save the Date- KAYS Conference Call December 20, 2017 2:00 PM EST
KAYS Shareholders and other interested parties are reminded to sign up for the Kaya Holdings Annual Shareholder Call on Wednesday, December 20, 2017 at 2:00 P.M. EST. The call is expected to last between 60-90 minutes. Among the topics to be discussed in the call are Kaya Shack™ store performance, new store development, OLCC licensing update, new brands to be introduced in 2018, an industry overview and the acquisition of farmland and the development of Kaya Farms™ 100K Square Foot Grow and Manufacturing Facilities.
About Kaya Holdings, Inc. (www.kayaholdings.com)
KAYS (OTCQB:KAYS), through subsidiaries, produces, distributes and sells legal premium medical and recreational cannabis products, including flower, concentrates and oils, and cannabis-infused foods.
In 2014, KAYS, became the first publicly traded company to own and operate a Medical Marijuana Dispensary. KAYS presently operates three Kaya Shack™ OLCC licensed marijuana retail stores to service the legal medical and recreational marijuana market in Oregon, with store number four currently under construction and expected to open in Q-4 of 2017. Additionally, KAYS recently acquired a 26 acre parcel which it has targeted for development of the Kaya Farms™ Medical and Recreational Marijuana Grow and Manufacturing Complex.
IMPORTANT DISCLOSURE: KAYS is planning execution of its stated business objectives in accordance with current understanding of State and Local Laws and Federal Enforcement Policies and Priorities as it relates to Marijuana (as outlined in the Justice Department's Cole Memo dated August 29, 2013), and plan to proceed cautiously with respect to legal and compliance issues. Potential investors and shareholders are cautioned that AFAI and MJAI will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana products, engaging in said activities or acquiring existing Cannabis production/sales operations). Advice of counsel with regard to specific activities of KAYS and MJAI, Federal, State or Local legal action or changes in Federal Government Policy and/or State and Local Laws may adversely affect business operations and shareholder value.
Forward Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
For more information contact Investor Relations: 561-210-7664